PURPOSE: Our aim was to investigate the role of computed tomography pulmonary angiography (CTPA) in the diagnosis of right ventricular dysfunction (RVD) and massive pulmonary thromboembolism (PTE). MATERIALS AND METHODS: We retrospectively involved a total of 61 patients. In CTPAs, pulmonary arterial obstruction index (PAOI), right ventricular/left ventricular diameter ratio (RV/LV), and superior vena cava (SVC) diameters were calculated, followed by echocardiography (ECHO), and clinical results were evaluated based on the reports available. RESULTS: CTPA findings that included PAOI, RV/LV ratio, and SVC diameter were, respectively, 54.9 ± 22.7 %, 1.58 ± 0.51, and 20.3 ± 0.2 mm in patients with RVD on ECHO, whereas corresponding values were, respectively, 37.8 ± 24.2 %, 1.32 ± 0.47, and 18.4 ± 3.3 mm in those without RVD (respectively, p = 0.006, p = 0.038, and p = 0.026). PAOI was 63.3 ± 22.0 % in patients among whom massive PTE was detected and 43.1 ± 23.9 % in the group without massive PTE (p = 0.01). As for mortality; given an RV/LV ratio >1.0, this ratio had 100 % sensitivity and 35.6 % specificity, whereas given a PAOI of ≥50 %, sensitivity and specificity were 83.3 % and 57.8 %, respectively. CONCLUSION: We concluded that in the patients with PTE, PAOI ≥50 % and RV/LV >1.0 in CTPA could be helpful to demonstrate RVD.
PURPOSE: Our aim was to investigate the role of computed tomography pulmonary angiography (CTPA) in the diagnosis of right ventricular dysfunction (RVD) and massive pulmonary thromboembolism (PTE). MATERIALS AND METHODS: We retrospectively involved a total of 61 patients. In CTPAs, pulmonary arterial obstruction index (PAOI), right ventricular/left ventricular diameter ratio (RV/LV), and superior vena cava (SVC) diameters were calculated, followed by echocardiography (ECHO), and clinical results were evaluated based on the reports available. RESULTS:CTPA findings that included PAOI, RV/LV ratio, and SVC diameter were, respectively, 54.9 ± 22.7 %, 1.58 ± 0.51, and 20.3 ± 0.2 mm in patients with RVD on ECHO, whereas corresponding values were, respectively, 37.8 ± 24.2 %, 1.32 ± 0.47, and 18.4 ± 3.3 mm in those without RVD (respectively, p = 0.006, p = 0.038, and p = 0.026). PAOI was 63.3 ± 22.0 % in patients among whom massive PTE was detected and 43.1 ± 23.9 % in the group without massive PTE (p = 0.01). As for mortality; given an RV/LV ratio >1.0, this ratio had 100 % sensitivity and 35.6 % specificity, whereas given a PAOI of ≥50 %, sensitivity and specificity were 83.3 % and 57.8 %, respectively. CONCLUSION: We concluded that in the patients with PTE, PAOI ≥50 % and RV/LV >1.0 in CTPA could be helpful to demonstrate RVD.
Authors: Rene Quiroz; Nils Kucher; U Joseph Schoepf; Florian Kipfmueller; Scott D Solomon; Philip Costello; Samuel Z Goldhaber Journal: Circulation Date: 2004-05-17 Impact factor: 29.690
Authors: Rutger W van der Meer; Peter M T Pattynama; Marco J L van Strijen; Annette A van den Berg-Huijsmans; Ieneke J C Hartmann; Hein Putter; Albert de Roos; Menno V Huisman Journal: Radiology Date: 2005-04-21 Impact factor: 11.105
Authors: U Joseph Schoepf; Nils Kucher; Florian Kipfmueller; Rene Quiroz; Philip Costello; Samuel Z Goldhaber Journal: Circulation Date: 2004-11-08 Impact factor: 29.690
Authors: Rafael Golpe; Luis A Pérez-de-Llano; Olalla Castro-Añón; Manuel Vázquez-Caruncho; Carlos González-Juanatey; Alejandro Veres-Racamonde; Concepción Iglesias-Moreira; María Carmen Fariñas Journal: Respir Med Date: 2010-04-24 Impact factor: 3.415
Authors: Alexandru Marginean; Andrew Putnam; Taishi Hirai; Anthony Serritella; Stephanie A Besser; Margaret Lee; Janet Friant; John Blair; Atman Shah; Sandeep Nathan; Jonathan Chung; Jonathan Paul Journal: J Thromb Thrombolysis Date: 2020-07 Impact factor: 2.300
Authors: Yvonne M Ende-Verhaar; Lucia J M Kroft; Inge C M Mos; Menno V Huisman; Frederikus A Klok Journal: PLoS One Date: 2017-11-28 Impact factor: 3.240